Earnings Preview For James River Group Hldgs

James River Group Hldgs (NASDAQ:JRVR) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that James River Group Hldgs will report an earnings per share (EPS) of $0.43.

James River Group Hldgs (NASDAQ:JRVR) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here’s what investors need to know before the announcement.

Analysts estimate that James River Group Hldgs will report an earnings per share (EPS) of $0.43.

James River Group Hldgs bulls will hope to hear the company to announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

Last quarter the company beat EPS by $0.02, which was followed by a 1.08% increase in the share price the next day.

Here’s a look at James River Group Hldgs’s past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.50 0.26 -0.40
EPS Actual 0.52 0.37 -1.81 -0.72
Price Change % 1.08% 8.12% -19.51% -2.07%

Stock Performance

Shares of James River Group Hldgs were trading at $24.99 as of October 28. Over the last 52-week period, shares are down 21.13%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for James River Group Hldgs visit their earnings calendar on our site.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

CBD Giant’s Challenging Year: Q4 Net Sales Slide By 27% But Net Loss Narrows 67% YoY

cbdMD reported a 27% year-over-year drop in net sales for the fourth quarter of 2023, totaling $5.7 million. The company attributed the decline to industry trends, reduced marketing spend, and lower wholesale pricing for its new high-strength products. For the full fiscal year 2023, net sales reached $24.2 million, down from $35.4 million in the previous year. Gross profit for the year was approximately $15 million, a decrease from $22.3 million in fiscal 2022. The company reported a net loss of about $23 million, compared to $70 million in 2022. Operating expenses fell to $24.2 million from $40 million in the prior year. cbdMD's working capital on September 30, 2023, was $3.4 million, down from $10.7 million on the same date in 2022. The company also launched its hempMD and ATRx brands in 2023, expanding its product channels into Amazon and other consumer products channels.

YCBD

Read More

Recap: Goldman Sachs BDC Q2 Earnings

Goldman Sachs BDC (NYSE:GSBD) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings Goldman Sachs BDC reported in-line EPS of $0.45 versus an estimate of $0.45.

GSBD